Alembic Pharmaceuticals has informed that the Board of Directors of the company at its meeting held today has approved the Issue of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of up to Rs 500 crores on Private Placement Basis under a shelf disclosure document in multiple tranches; and constituted NCD Committee for issue and allotment of NCDs. The time of commencement of the Board Meeting was 12:30 pm and the time of conclusion was 1:30 pm.
The above information is a part of company’s filings submitted to BSE.
